(UPI) -- Princeton University officials are mulling the use of Bexsero, a vaccine which can protect against serogroup B meningitis but is not approved for use in the U.S., after a seventh student contracted the disease.
Officials are expected to make a decision as early as Monday in response to the meningitis outbreak on campus, which has hospitalized seven students since March.